Bioimpacts

Papers
(The H4-Index of Bioimpacts is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines39
The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis28
Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems22
Characterization of isolated compounds from Morus spp. and their biological activity as anticancer molecules15
High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy14
Synthesis and characterization of actively HER-2 Targeted Fe3O4@Au nanoparticles for molecular radiosensitization of breast cancer14
Evaluating the presence of deregulated tumoral onco-microRNAs in serum-derived exosomes of gastric cancer patients as noninvasive diagnostic biomarkers12
Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy11
Can early treatment of twitcher mice with high dose AAVrh10-GALC eliminate the need for BMT?11
Preparation and evaluation of a polycaprolactone/chitosan/propolis fibrous nanocomposite scaffold as a tissue engineering skin substitute11
A fuzzy logic-based computational method for the repurposing of drugs against COVID-1910
miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI10
Injectable thermosensitive chitosan/gelatin hydrogel for dental pulp stem cells proliferation and differentiation10
0.80111694335938